Here are relevant reports on : drug-discovery-market
-
Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029
The global AI in drug discovery market growth is primed to transition from USD 1.86 billion in 2024 to USD 6.89 billion by 2029, showcasing a strong CAGR of 29.9%. The growth of this market is primarily driven by the growing number of cross-industry collaborations and partnerships, the need to control drug discovery & development costs and reduce the overall time taken in this process, and the increasing focus on oncology indication.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028
Biosimilars market growth is primed to transition from 29.4 billion in 2023 to USD 66.9 billion by 2028, showcasing a strong CAGR of 17.8%. This market is driven by increasing demand for cost-effective treatments amidst rising chronic disease rates and the patent expirations of major biologics. Key trends include the rapid approval and adoption of biosimilars, particularly in oncology.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
Drug Screening Market Size by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Global Forecast to 2029
The size of global drug screening market in terms of revenue was estimated to be worth USD 9.1 billion in 2024 and is poised to reach USD 19.5 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Glioblastoma Multiforme Drug Market by Therapy (Chemotherapy, Immunotherapy), Drug Class, End Use, Region (North America, Europe, Asia Pacific, and Rest of the World) – Global Forecast to 2027
The global glioblastoma multiforme drug market is projected to reach USD ~880 million by 2027 from USD 600 million in 2022, at a CAGR of 8% during the forecast period
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Drug Device Combination – (2009 - 2014)
This report analyzes the basic structure of the drug-device combination market and its various submarkets. Individual markets for major products such as anti-microbial catheters, wound-care products, bone-graft substitutes, bone cement, drug-eluting stents, photodynamic therapy, artificial pancreas, and steroid eluting electrodes are further broken down into their respective sub-segments based on products, technology and applications.
- Published: November 2009
- Price: $ 4950
- TOC Available:
-
Adhesive for Drug Delivery System Market by Resin Type, Technology and Geography - Global Forecast to 2019
This study estimates the global adhesive for drug delivery system for 2013 and projects the expected demand of the same by 2019. This market research study provides a detailed qualitative and quantitative analysis of the global adhesive for drug delivery system. It also includes a comprehensive review of major market drivers, restraints, opportunities, winning imperatives, challenges, and key issues in the market. The market is further segmented and forecast based by major regions North America, Europe, Asia-Pacific and RoW (Rest of the World). Market size for major countries of each region in terms of volume and value are covered.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Drug Eluting Stents Market - 2019 By Types, Application & Geography
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Metabolomics Market by Product (GC,UPLC, CE, Surface based Mass Analysis), Application (Biomarker Discovery, Drug Discovery,Functional Genomics), Indication (Cardiology, Oncology,Inborn Errors), End User (Academic Institute,CROs) & Region - Global Forecast to 2025
The global metabolomics market in terms of revenue was estimated to be worth $1.9 billion in 2020 and is poised to reach $4.1 billion by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: December 2020
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
